S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
Log in
NASDAQ:CRSA

Crescent Acquisition Competitors

$10.19
-0.01 (-0.10 %)
(As of 03/1/2021 12:00 AM ET)
Add
Compare
Today's Range
$10.18
Now: $10.19
$10.25
50-Day Range
$10.14
MA: $10.41
$11.33
52-Week Range
$9.10
Now: $10.19
$13.11
Volume165,795 shs
Average Volume1.07 million shs
Market Capitalization$318.44 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Crescent Acquisition (NASDAQ:CRSA) Vs. CMLF, TPGY, AJAX, AJAX, BTWN, and ACIC

Should you be buying CRSA stock or one of its competitors? Companies in the industry of "shell companies" are considered alternatives and competitors to Crescent Acquisition, including CM Life Sciences (CMLF), TPG Pace Beneficial Finance (TPGY), Ajax I (AJAX), Ajax I (AJAX), Bridgetown (BTWN), and Atlas Crest Investment (ACIC).

CM Life Sciences (NASDAQ:CMLF) and Crescent Acquisition (NASDAQ:CRSA) are both small-cap financial services companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.

Analyst Recommendations

This is a breakdown of current ratings for CM Life Sciences and Crescent Acquisition, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
CM Life Sciences0000N/A
Crescent Acquisition0000N/A

Earnings & Valuation

This table compares CM Life Sciences and Crescent Acquisition's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CM Life SciencesN/AN/AN/AN/AN/A
Crescent AcquisitionN/AN/AN/AN/AN/A

Profitability

This table compares CM Life Sciences and Crescent Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CM Life SciencesN/AN/AN/A
Crescent AcquisitionN/AN/AN/A

TPG Pace Beneficial Finance (NYSE:TPGY) and Crescent Acquisition (NASDAQ:CRSA) are both small-cap financial services companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, earnings, valuation and risk.

Profitability

This table compares TPG Pace Beneficial Finance and Crescent Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
TPG Pace Beneficial FinanceN/AN/AN/A
Crescent AcquisitionN/AN/AN/A

Earnings & Valuation

This table compares TPG Pace Beneficial Finance and Crescent Acquisition's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TPG Pace Beneficial FinanceN/AN/AN/AN/AN/A
Crescent AcquisitionN/AN/AN/AN/AN/A

Analyst Recommendations

This is a summary of recent recommendations for TPG Pace Beneficial Finance and Crescent Acquisition, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
TPG Pace Beneficial Finance0000N/A
Crescent Acquisition0000N/A

Crescent Acquisition (NASDAQ:CRSA) and Ajax I (NYSE:AJAX) are both small-cap financial services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, dividends, earnings, risk and profitability.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Crescent Acquisition and Ajax I, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Crescent Acquisition0000N/A
Ajax I0000N/A

Valuation & Earnings

This table compares Crescent Acquisition and Ajax I's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Crescent AcquisitionN/AN/AN/AN/AN/A
Ajax IN/AN/AN/AN/AN/A

Profitability

This table compares Crescent Acquisition and Ajax I's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Crescent AcquisitionN/AN/AN/A
Ajax IN/AN/AN/A

Crescent Acquisition (NASDAQ:CRSA) and Ajax I (NYSE:AJAX) are both small-cap financial services companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, dividends and valuation.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Crescent Acquisition and Ajax I, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Crescent Acquisition0000N/A
Ajax I0000N/A

Valuation and Earnings

This table compares Crescent Acquisition and Ajax I's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Crescent AcquisitionN/AN/AN/AN/AN/A
Ajax IN/AN/AN/AN/AN/A

Profitability

This table compares Crescent Acquisition and Ajax I's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Crescent AcquisitionN/AN/AN/A
Ajax IN/AN/AN/A

Crescent Acquisition (NASDAQ:CRSA) and Bridgetown (NASDAQ:BTWN) are both small-cap financial services companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, dividends and valuation.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Crescent Acquisition and Bridgetown, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Crescent Acquisition0000N/A
Bridgetown0000N/A

Valuation and Earnings

This table compares Crescent Acquisition and Bridgetown's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Crescent AcquisitionN/AN/AN/AN/AN/A
BridgetownN/AN/AN/AN/AN/A

Profitability

This table compares Crescent Acquisition and Bridgetown's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Crescent AcquisitionN/AN/AN/A
BridgetownN/AN/AN/A

Crescent Acquisition (NASDAQ:CRSA) and Atlas Crest Investment (NYSE:ACIC) are both small-cap financial services companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, dividends and valuation.

Valuation and Earnings

This table compares Crescent Acquisition and Atlas Crest Investment's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Crescent AcquisitionN/AN/AN/AN/AN/A
Atlas Crest InvestmentN/AN/AN/AN/AN/A

Profitability

This table compares Crescent Acquisition and Atlas Crest Investment's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Crescent AcquisitionN/AN/AN/A
Atlas Crest InvestmentN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Crescent Acquisition and Atlas Crest Investment, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Crescent Acquisition0000N/A
Atlas Crest Investment0000N/A


Crescent Acquisition Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
CMLF
CM Life Sciences
0.0$20.98-4.6%$1.16 billionN/A0.00Increase in Short Interest
Gap Down
TPGY
TPG Pace Beneficial Finance
0.0$25.00-17.4%$1.13 billionN/A0.00Increase in Short Interest
Gap Down
AJAX
Ajax I
0.0$11.60-0.5%$1.04 billionN/A0.00Increase in Short Interest
Gap Down
AJAX
Ajax I
0.0$11.60-0.5%$1.04 billionN/A0.00Increase in Short Interest
Gap Down
BTWN
Bridgetown
0.0$13.88-2.7%$1.03 billionN/A0.00Gap Down
ACIC
Atlas Crest Investment
0.0$12.85-7.4%$827.22 millionN/A0.00Gap Down
BOAC
Bluescape Opportunities Acquisition
0.0$10.78-0.6%$818.61 millionN/A0.00Decrease in Short Interest
HZON
Horizon Acquisition Co. II
0.0$10.29-0.6%$682.17 millionN/A0.00Decrease in Short Interest
GHVI
Gores Holdings VI
0.0$18.11-1.9%$679.13 millionN/A0.00Gap Down
LCY
Landcadia Holdings III
0.0$10.23-1.9%$658.56 millionN/A0.00
HAAC
Health Assurance Acquisition
0.0$11.83-0.7%$655.09 millionN/A0.00Gap Down
BOWX
BowX Acquisition
0.0$10.50-0.0%$633.94 millionN/A0.00Decrease in Short Interest
News Coverage
Gap Down
CFII
CF Finance Acquisition Corp. II
0.0$9.96-0.1%$633.46 millionN/A0.00High Trading Volume
TPG Pace Tech Opportunities logo
PACE
TPG Pace Tech Opportunities
0.0$10.75-0.7%$604.69 millionN/A0.00Increase in Short Interest
AGCB
Altimeter Growth Corp. 2
0.3$11.78-1.0%$600.78 millionN/A0.00
HOL
Holicity
0.0$15.74-11.4%$590.25 millionN/A0.00Increase in Short Interest
News Coverage
Gap Down
SPNV
Supernova Partners Acquisition
0.0$11.06-1.5%$556.46 millionN/A0.00
CTAC
Cerberus Telecom Acquisition
0.0$15.77-5.5%$534.97 millionN/A0.00Decrease in Short Interest
MAAC
Montes Archimedes Acquisition
0.0$10.17-0.3%$534.66 millionN/A0.00Decrease in Short Interest
NGAC
NextGen Acquisition
0.0$11.22-2.8%$525.94 millionN/A0.00Decrease in Short Interest
CTAQ
Carney Technology Acquisition Corp. II
0.0$10.14-0.1%$519.30 millionN/A0.00
IIAC
Investindustrial Acquisition
0.0$10.30-1.7%$518.22 millionN/A0.00
TSIA
TS Innovation Acquisitions
0.0$13.76-6.1%$516 millionN/A0.00Increase in Short Interest
News Coverage
Gap Down
LUXA
Lux Health Tech Acquisition
0.0$11.50-0.8%$495.94 millionN/A0.00Increase in Short Interest
HIGA
H.I.G. Acquisition
0.0$10.37-0.4%$474.30 millionN/A0.00Increase in Short Interest
FSRV
FinServ Acquisition
0.0$14.17-0.6%$452.24 millionN/A0.00Increase in Short Interest
Gap Down
NSTB
Northern Star Investment Corp. II
0.0$10.16-1.4%$444.50 millionN/A0.00
INAQ
INSU Acquisition Corp. II
0.0$14.70-2.0%$438.55 millionN/A0.00
GFX
Golden Falcon Acquisition
0.0$10.05-0.9%$433.41 millionN/A0.00
PIAI
Prime Impact Acquisition I
0.0$10.27-0.8%$416.05 millionN/A0.00
MUDS
Mudrick Capital Acquisition Co. II
0.0$10.14-0.1%$400.84 millionN/A0.00
VIH
VPC Impact Acquisition
0.3$15.45-3.1%$400.50 millionN/A0.00Gap Down
IGAC
IG Acquisition
0.0$10.23-0.2%$395.13 millionN/A0.00Decrease in Short Interest
BTNB
Bridgetown 2
0.0$11.81-0.7%$383.83 millionN/A0.00News Coverage
Gap Down
DCRB
Decarbonization Plus Acquisition
0.0$12.89-8.7%$365.08 millionN/A0.00Increase in Short Interest
Gap Down
HCAR
Healthcare Services Acquisition
0.0$10.02-0.2%$360.72 millionN/A0.00
GIK
GigCapital3
0.0$13.82-14.7%$357.84 millionN/A0.00High Trading Volume
News Coverage
Gap Down
CND
Concord Acquisition
0.0$10.04-0.3%$353.93 millionN/A0.00
ATAC
Altimar Acquisition
0.0$10.09-6.2%$346.84 millionN/A0.00Gap Up
ASPL
Aspirational Consumer Lifestyle
0.0$11.28-3.1%$338.04 millionN/A0.00Increase in Short Interest
FTIV
Fintech Acquisition Corp. IV
1.7$10.62-0.2%$334.32 millionN/A0.00Decrease in Short Interest
HPX
HPX
0.0$10.25-0.0%$324.16 millionN/A0.00Decrease in Short Interest
Gap Down
BSN
Broadstone Acquisition
0.0$10.25-1.0%$312.93 millionN/A0.00Increase in Short Interest
PIPP
Pine Island Acquisition
1.0$11.05-0.2%$304.86 millionN/A0.00
CCAC
CITIC Capital Acquisition
0.3$10.84-3.0%$299.18 millionN/A0.00Increase in Short Interest
IACA
ION Acquisition Corp 1
0.0$11.45-3.9%$296.27 millionN/A0.00Decrease in Short Interest
ARBG
Aequi Acquisition
0.0$10.22-0.1%$293.83 millionN/A0.00High Trading Volume
MTAC
MedTech Acquisition
0.0$10.26-0.2%$282.15 millionN/A0.00
LEAP
Ribbit LEAP
0.0$13.97-1.1%$279.93 millionN/A0.00Decrease in Short Interest
News Coverage
Gap Down
LFTR
Lefteris Acquisition
0.0$10.55-0.3%$273.11 millionN/A0.00Decrease in Short Interest
This page was last updated on 3/2/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.